跳至主要内容
临床试验/NCT03905252
NCT03905252已完成不适用

Biomarkers for Human Heart Failure

Mayo Clinic1 个研究点 分布在 1 个国家目标入组 535 人开始时间: 2009年8月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
Mayo Clinic
入组人数
535
试验地点
1
主要终点
uAGT levels in high-risk chronic HF patients

研究概览

简要总结

The purpose of this study is to establish the various ranges of proteins that can be assayed in the plasma and urine from hospitalized patients with all classes of heart failure and/or STEMI (ST-segment elevation myocardial infarction)/NSTEMI (Non-ST-segment elevation myocardial infarction), as well as history reviews.

详细描述

Schematic Design of the Study: Single blood draw, one random urine and 24-hr urine collection from hospitalized patients with chronic/acute heart failure and/or STEMI-NSTEMI. If there should be a subsequent hospitalization,another collection of a 45 ml blood sample, random urine and one 24-hour urine collection may be completed if indicated at initial hospitalization.

Aims:

The purpose of this study is to attempt to establish the various ranges of proteins that can be assayed from the plasma and urine of patients with all classes of heart failure and MI (myocardial infarction). Follow-up hospitalizations may result in another 45 ml blood draw, random urine and 24-hr. urine collection to evaluate the outcome of the heart failure treatment used with the previous hospitalization, if indicated in consent. A history review will be necessary as well.

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Diagnosis of Acute decompensated heart failure

排除标准

  • Hemoglobin less than 10, active cancer, or amyloidosis Patient with dialysis

结局指标

主要结局

uAGT levels in high-risk chronic HF patients

时间窗: 10 years

This study will provide new knowledge of the pathology and outcomes predicted by the use of uAGT in symptomatic chronic HF patients at high risk for future hospitalization and death.

Natriuretic peptide levels in ADHF patients

时间窗: 20 years

new knowledge of pathology and outcomes in ADHF patients

次要结局

未报告次要终点

研究者

发起方
Mayo Clinic
申办方类型
Other
责任方
Principal Investigator
主要研究者

John C Burnett

Principal Investigator

Mayo Clinic

研究点 (1)

Loading locations...

相似试验